Vivus Inc (VVUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VVUS | AZN | AMGN | GILD | VRTX |
| Company | Vivus Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.4860 | 92.65 | 328.65 | 124.56 | 456.83 |
| High | 0.5000 | 92.88 | 329.77 | 125.00 | 458.36 |
| Low | 0.4600 | 92.36 | 325.83 | 122.95 | 453.40 |
| Latest | 0.4665 | 92.51 | 328.69 | 123.18 | 453.74 |
| Change | -0.0535 | -0.01 | -0.94 | -1.73 | -6.04 |
| % Change | -10.29% | -0.01% | -0.29% | -1.38% | -1.31% |
| Volume | 2,026,800 | 1,730,500 | 1,256,100 | 3,256,000 | 686,100 |
| 20-Day Average Volume | 2,106,530 | 5,089,865 | 3,022,525 | 6,860,885 | 1,346,380 |
| Previous Close | 0.5200 | 92.52 | 329.63 | 124.91 | 459.78 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7599 | 91.14 | 327.87 | 122.59 | 452.67 |
| 20-Day Raw Stochastic | 3.96% | 84.56% | 47.96% | 54.22% | 73.50% |
| 20-Day Relative Strength | 31.95 | 59.88 | 53.11 | 51.22 | 56.15 |
| Weighted Alpha | -90.53 | +42.22 | +25.27 | +30.96 | +11.23 |
| Today's Opinion | 100% Sell | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Last Month's Opinion | 96% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -17.96% since 07/09/20 | +1.05% since 12/22/25 | -0.81% since 12/22/25 | -0.79% since 12/22/25 | -1.43% since 12/22/25 |
| Low | 0.4369 on 07/13/20 | 91.94 on 12/23/25 | 325.83 on 12/30/25 | 122.95 on 12/30/25 | 453.40 on 12/30/25 |
| High | 0.6800 on 07/14/20 | 93.10 on 12/23/25 | 334.38 on 12/24/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 1-Month | |||||
| %Chg | -59.43% since 06/16/20 | -0.23% since 11/28/25 | -4.85% since 11/28/25 | -2.11% since 11/28/25 | +4.64% since 11/28/25 |
| Low | 0.4369 on 07/13/20 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 423.45 on 12/01/25 |
| High | 1.1841 on 06/18/20 | 93.10 on 12/23/25 | 346.38 on 12/03/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 3-Month | |||||
| %Chg | -66.20% since 04/16/20 | +20.58% since 09/30/25 | +16.47% since 09/30/25 | +10.97% since 09/30/25 | +15.86% since 09/30/25 |
| Low | 0.4369 on 07/13/20 | 80.48 on 11/04/25 | 283.00 on 10/01/25 | 108.46 on 10/02/25 | 392.49 on 10/01/25 |
| High | 1.4700 on 06/08/20 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 464.44 on 12/24/25 |
| 6-Month | |||||
| %Chg | -82.72% since 01/16/20 | +32.38% since 06/30/25 | +17.72% since 06/30/25 | +11.10% since 06/30/25 | +1.92% since 06/30/25 |
| Low | 0.4369 on 07/13/20 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 4.5500 on 03/31/20 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,335 | 286,946,304 | 177,499,504 | 154,973,344 | 116,654,920 |
| Shares Outstanding, K | 17,867 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 69,760,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -31,500,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 19,630,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -5,210,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | -0.84 | 0.31 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 08/04/20 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.33 | 15.22 | 15.23 | 30.24 |